Ms. Silvina Samy was born and grew up in Braga (Portugal). She started her research career investigating and developing distinct 3D therapeutic strategies aimed for spinal cord injuries and peripheral nerve regeneration; exploring the knowledge from the fields of Tissue Engineering, Neurosciences and Stem Cells Research at the 3B’s Research Group (Portugal) and the Life and Health Sciences Research Institute (ICVS, Portugal). Next, she joined the Unit of Neuronal Regeneration of the Institute of Health Carlos III (ISCIII, Spain) for a 6 months traineeship in the framework of INOV Contacto program (fostered by the Portuguese government). Later, during her master thesis project she focused on the design, testing and optimization of microfluidic platforms for nucleic acid separation and purification aimed for research and quality control purposes. In 2016, she joined the International Iberian Nanotechnology Laboratory (INL, Portugal) as a research assistant focused on the preclinical validation of a microfluidics-based system for sensitive and minimally invasive rare cell isolation and characterization to monitor the oncological disease progression.
Her main interest is to add value to society by bridging the gap between academia and the healthcare industry through the development of innovative diagnostic and monitoring systems. Such systems could be used in the fight against several diseases with the purpose of detecting disease early onset; ultimately impacting the immediate clinical decisions to be made and consequently the patients’ quality of life, while alleviating the global healthcare costs.